Waiting on an update on Phase 2 trials in melanoma patients expected in Q4. Stock could rally from Fibonacci setup after the conference.
Buy zone: 2.70
Profit zone: 3.00 or higher
Stop zone: 2.55 or lower
Buy zone: 2.70
Profit zone: 3.00 or higher
Stop zone: 2.55 or lower
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。